When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma FDA mulls compounding for peptides previously flagged over safety risks BioSpace The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York